BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Reference Citation Analysis]
2 Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr 2022;8:774030. [DOI: 10.3389/fnut.2021.774030] [Reference Citation Analysis]
3 Kardashian A, Wilder J, Terrault NA, Price JC. Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action. Hepatology 2021;73:811-20. [PMID: 33150599 DOI: 10.1002/hep.31605] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
5 Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:311-8. [DOI: 10.1111/apt.15821] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Alexopoulos T, Vasilieva L, Kontogianni MD, Mani I, Alexopoulou A. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately. Aliment Pharmacol Ther 2021;54:981-2. [PMID: 34506659 DOI: 10.1111/apt.16564] [Reference Citation Analysis]
7 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases. J Clin Med 2020;9:E1570. [PMID: 32455875 DOI: 10.3390/jcm9051570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yang W, Wang X, Yu Z, Li C, Sun M, Li Y, Hui Y, Guo G, Fan X, Jiang K, Sun C. Low Levels of Serum Zinc Associate with Malnutrition Risk Assessed by the Royal Free Hospital-Nutritional Prioritizing Tool in Cirrhosis. Biol Trace Elem Res 2021. [PMID: 34791623 DOI: 10.1007/s12011-021-03033-1] [Reference Citation Analysis]
9 Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ikeda N, Aizawa N, Nishimura T, Iijima H, Nishiguchi S. Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases. Diagnostics (Basel) 2020;10:E238. [PMID: 32325995 DOI: 10.3390/diagnostics10040238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;:1-10. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Reference Citation Analysis]
11 Pimentel CFMG, Amaral ACC, Gonzalez AM, Lai M, Mota DO, Ferraz MLG, Junior WM, Kondo M. Six-minute walking test performance is associated with survival in cirrhotic patients. World J Hepatol 2021; 13(11): 1791-1801 [PMID: 34904046 DOI: 10.4254/wjh.v13.i11.1791] [Reference Citation Analysis]
12 Nishikawa H, Yoh K, Enomoto H, Nishiguchi S, Iijima H. Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases. Diagnostics (Basel) 2021;11:1262. [PMID: 34359344 DOI: 10.3390/diagnostics11071262] [Reference Citation Analysis]
13 Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM; AFEF and SFD. Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. Diabetes Metab 2021;47:101272. [PMID: 34363981 DOI: 10.1016/j.diabet.2021.101272] [Reference Citation Analysis]
14 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)02174-7. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Reference Citation Analysis]
15 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. Reply to "Comments on the Editor Re: The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097.". Nutrients 2020;12:E869. [PMID: 32213917 DOI: 10.3390/nu12030869] [Reference Citation Analysis]
16 Lefere S, Onghena L, Vanlander A, van Nieuwenhove Y, Devisscher L, Geerts A. Bariatric surgery and the liver-Mechanisms, benefits, and risks. Obes Rev 2021;22:e13294. [PMID: 34002452 DOI: 10.1111/obr.13294] [Reference Citation Analysis]
17 Kishino K, Enomoto H, Shimono Y, Moriwaki EI, Nishikawa H, Nishimura T, Iwata Y, Iijima H, Nishiguchi S. Association of an Overhydrated State With the Liver Fibrosis and Prognosis of Cirrhotic Patients. In Vivo 2020;34:1347-53. [PMID: 32354929 DOI: 10.21873/invivo.11912] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 D'Amico G, Bernardi M, Angeli P. TOWARDS A NEW DEFINITION OF DECOMPENSATED CIRRHOSIS. J Hepatol 2021:S0168-8278(21)00438-4. [PMID: 34157322 DOI: 10.1016/j.jhep.2021.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Topan MM, Sporea I, Dănilă M, Popescu A, Ghiuchici AM, Lupuşoru R, Şirli R. Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis. Front Nutr 2021;8:766451. [PMID: 34746216 DOI: 10.3389/fnut.2021.766451] [Reference Citation Analysis]
20 Ponziani FR, Picca A, Marzetti E, Calvani R, Conta G, Del Chierico F, Capuani G, Faccia M, Fianchi F, Funaro B, Josè Coelho-Junior H, Petito V, Rinninella E, Paroni Sterbini F, Reddel S, Vernocchi P, Cristina Mele M, Miccheli A, Putignani L, Sanguinetti M, Pompili M, Gasbarrini A; GuLiver study group. Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia. Liver Int 2021;41:1320-34. [PMID: 33713524 DOI: 10.1111/liv.14876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study. Ann Transl Med 2021;9:624. [PMID: 33987322 DOI: 10.21037/atm-20-6901] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bhanji RA, Saiman Y, Watt KD. Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation. Clin Liver Dis (Hoboken) 2021;17:2-5. [PMID: 33552477 DOI: 10.1002/cld.1000] [Reference Citation Analysis]
23 Badran H, Elsabaawy MM, Ragab A, Aly RA, Alsebaey A, Sabry A. Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients. Asian Pac J Cancer Prev 2020;21:3285-90. [PMID: 33247686 DOI: 10.31557/APJCP.2020.21.11.3285] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Nakamura T, Yamashita M, Uchida S, Maekawa E, Reed JL, Yamaoka-Tojo M, Matsunaga A, Ako J. Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure. Sci Rep 2021;11:3715. [PMID: 33580115 DOI: 10.1038/s41598-020-80641-2] [Reference Citation Analysis]
25 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Factors Associated With Longitudinal QOL Change in Patients With Chronic Liver Diseases. In Vivo 2021;35:2451-6. [PMID: 34182530 DOI: 10.21873/invivo.12524] [Reference Citation Analysis]
26 Koh FH, Loh CH, Tan WJ, Ho LML, Yen D, Chua JMW, Kok SSX, Sivarajah SS, Chew MH, Foo FJ. Structured presurgery prehabilitation for aged patients undergoing elective surgery significantly improves surgical outcomes and reduces cost: A nonrandomized sequential comparative prospective cohort study. Nutr Clin Pract 2021. [PMID: 34861063 DOI: 10.1002/ncp.10787] [Reference Citation Analysis]
27 Nishikawa H, Yoh K, Enomoto H, Ikeda N, Takashima T, Aizawa N, Nishimura T, Nishiguchi S, Iijima H. Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases. In Vivo 2021;35:363-71. [PMID: 33402485 DOI: 10.21873/invivo.12267] [Reference Citation Analysis]
28 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Health-Related Quality of Life and Frailty in Chronic Liver Diseases. Life (Basel) 2020;10:E76. [PMID: 32456292 DOI: 10.3390/life10050076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Casas Deza D, Betoré Glaria ME, Sanz-París A, Lafuente Blasco M, Fernández Bonilla EM, Bernal Monterde V, Arbonés-Mainar JM, Fuentes Olmo J. Response to "Malnutrition in patients with cirrhosis: Screen or treat?". Nutr Clin Pract 2021. [PMID: 34339062 DOI: 10.1002/ncp.10748] [Reference Citation Analysis]
30 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Clinical impact of the finger-circle test in patients with liver diseases. Hepatol Res 2021;51:603-13. [PMID: 33772972 DOI: 10.1111/hepr.13639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Guarino M, Cossiga V, Becchetti C, Invernizzi F, Lapenna L, Lavezzo B, Lenci I, Merli M, Pasulo L, Zanetto A, Burra P, Morisco F; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF). Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature. Dig Liver Dis 2021:S1590-8658(21)00811-2. [PMID: 34789397 DOI: 10.1016/j.dld.2021.10.010] [Reference Citation Analysis]
32 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Reference Citation Analysis]
33 Casas Deza D, Betoré Glaria ME, Sanz-París A, Lafuente Blasco M, Fernández Bonilla EM, Bernal Monterde V, Arbonés Mainar JM, Fuentes Olmo J. Mini Nutritional Assessment - Short Form Is a Useful Malnutrition Screening Tool in Patients with Liver Cirrhosis, Using the Global Leadership Initiative for Malnutrition Criteria as the Gold Standard. Nutr Clin Pract 2021;36:1003-10. [PMID: 33817839 DOI: 10.1002/ncp.10640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 Zeng X, Shi ZW, Yu JJ, Wang LF, Luo YY, Jin SM, Zhang LY, Tan W, Shi PM, Yu H, Zhang CQ, Xie WF. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle 2021;12:1948-58. [PMID: 34520115 DOI: 10.1002/jcsm.12797] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Reference Citation Analysis]
36 Meyer F, Bannert K, Wiese M, Esau S, Sautter LF, Ehlers L, Aghdassi AA, Metges CC, Garbe LA, Jaster R, Lerch MM, Lamprecht G, Valentini L. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis. Int J Mol Sci 2020;21:E5357. [PMID: 32731496 DOI: 10.3390/ijms21155357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
37 Nishikawa H, Yoh K, Enomoto H, Ikeda N, Aizawa N, Koriyama T, Nishimura T, Nishiguchi S, Iijima H. Anthropometric Measurements and Frailty in Patients with Liver Diseases. Diagnostics (Basel). 2020;10:433. [PMID: 32630551 DOI: 10.3390/diagnostics10060433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Altajar S, Baffy G. Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol 2020;8:414-23. [PMID: 33447525 DOI: 10.14218/JCTH.2020.00065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wang X, Feng H, Hui Y, Zhao T, Mao L, Fan X, Cui B, Lin L, Zhang J, Wang B, Yu Q, Zhao X, Sun C. A predictive nomogram incorporating gait speed for all-cause mortality in hospitalized cirrhotics. Postgrad Med 2021;133:680-7. [PMID: 34029498 DOI: 10.1080/00325481.2021.1934494] [Reference Citation Analysis]
40 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points. In Vivo 2020;34:2549-59. [PMID: 32871784 DOI: 10.21873/invivo.12072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lin FP, Visina JM, Bloomer PM, Dunn MA, Josbeno DA, Zhang X, Clemente-Sanchez A, Tevar AD, Hughes CB, Jakicic JM, Duarte-Rojo A. Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. Am J Gastroenterol 2021. [PMID: 34313620 DOI: 10.14309/ajg.0000000000001376] [Reference Citation Analysis]
42 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases. In Vivo. 2020;34:2561-2569. [PMID: 32871785 DOI: 10.21873/invivo.12073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]